Lynne Lederman



Lynne Lederman


Independent Journalist









Dr. Lederman received her Ph.D. in Molecular Biology and Virology from Cornell University Graduate School of Medical Sciences. Her thesis work on retroviruses and oncogenes was conducted at the Sloan Kettering Institute for Cancer Research. Her academic post-doctoral research involved retroviruses, oncogenes, and the biochemistry of insulin action. She then worked in the biotechnology industry developing single-chain antibodies, new cloning vectors, and viral diagnostics, before turning to medical writing full time. She has published results of her original research in the fields of virology, immunology, and molecular biology.
Dr. Lederman served as a patient advocate and teams researcher for the NCI-ASCO Teams in Cancer Care Project and was first author on the patient advocate commentary in the Journal of Oncology Practice special edition on Teams Research and co-author of one of the teams research publications. She was a columnist for JOP, and helped the International Myeloma Foundation Nurse Leadership Board prepare 2 series of 6 manuscripts each for the Clinical Journal of Oncology Nursing on clinical nursing guidelines for managing the side effects of novel anti-myeloma agents, and articles on clinical trial results for the Journal of Clinical Oncology and the six-article supplement to the Clinical Journal of Oncology Nursing on clinical nursing guidelines for long term care plans for patients with myeloma
Dr. Lederman has covered many medical conferences, including ASCO, ASH, ESMO, ASTRO, EULAR, SABCS, and the International Myeloma Workshops; her reports have been published in the ASCO Daily News, ASH News Daily, The Oncology Nurse, Value-Based Cancer Care, Oncology Business Review, American Journal of Managed Care, Targeted Oncology, MD Conference Express, OncLive, DocGuide, Cure Today, First Word Pharma, and others.
Dr. Lederman is experienced in writing scientific papers for the peer-reviewed literature, medical/legal book chapters, grants, preclinical trial summaries, final clinical trial reports, investigators’ brochures, clinical trial protocols, and training material for MDs, medical science liaisons, and pharmaceutical sales reps. In addition, she has prepared literature reviews, literature and meeting summaries, standard operating procedures, and batch production records. In addition to expertise in the fields of oncology, immunology, virology, microbiology, molecular biology, clinical diagnostics, gastroenterology, autoimmune diseases, oxygen therapeutics, and general medical sciences.
Dr. Lederman is a member of the American Society of Hematology (ASH) the American Society of Clinical Oncology (ASCO), Association of Health Care Journalists (AHCJ), and the National Association of Science Writers (NASW). She also has a M.S. in Parasitology from Cornell University, and is a registered Medical Technologist, MT(ASCP).


oncology, hematology, medical conference coverage, patient advocacy




Member since: